Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
translational research - search results
If you're not happy with the results, please do another search
Oestrogen signalling, environmental chemicals & links with breast cancer
Members of the Breast Cancer & Environment Research Program walk us through what we need to know about oestrogen signalling, including environmental chemicals & links with breast cancer.
Australia’s medical innovation approach: Is it suitable for regenerative medicine?
Australia has committed to investing heavily in its medical future – but will it be ready for the regenerative medicine revolution? John Gardner from Monash University and Michael Morrison from the University of Oxford provide the answer.
The effects of vaping on vascular health
Mary Rezk-Hanna, PhD from the University of California, Los Angeles, studies the short-term effects of vaping on vascular health - she argues that electronic vaping is harmful and that a “safer” alternative to traditional hookah smoking is anything but safe.
Study finds suicidal thoughts in veterans did not increase during pandemic
A study by Yale University, published in JAMA Psychiatry, says that suicidal thoughts in veterans remained stable throughout the isolation of the pandemic.
Investing in the future of neuroscience
Nina Schor, Deputy Director and Acting Scientific Director of NINDS, underlines the importance of investing in the future of neuroscience.
Richard Francis – Stroke Association
Richard is Head of Research at the Stroke Association, where he leads the research programme, implementing the charity’s research strategy.
Accelerating the discovery, manufacture and translation of biomedical materials
The Henry Royce Institute is enhancing the UK’s position as an international leader in the field of biomedical materials, systems and devices.
Treating vision-related conditions
Professor Heather Sheardown from McMaster University provides detail about treating vision-related conditions, including injectable, in situ gelling systems.
Reconstructive Dentistry focus
In this interview, Mutlu Özcan, Prof Dr Dr hc, PhD from University of Zürich, lavishes us with details about Reconstructive Dentistry.
Bioinformatics focus: Can we break the glycocode?
Frederique Lisacek from SIB Swiss Institute of Bioinformatics, provides the computer-based tools for exploring ways of breaking the glycocode.
Scientists identify gene that could protect against severe COVID
A team at Newcastle University have identified a gene, HLA-DRB1*04:01, which could be responsible for individuals who are asymptomatic - suggesting that the gene offers some protection against severe COVID.
A biotech shield for cowpea against the major insect pests
Jose M. Barrero, Donald J. MacKenzie, Richard E. Goodman and T.J.V. Higgins provide an in-depth look at what we need to know about a biotech shield for cowpea against the major insect pests.
Building readiness for innovative health technologies
Senior Researcher in Social Science Michael Morrison explains why disruptive technologies need institutional and systemic readiness to truly realise the benefits of healthcare innovation.
Study examines immune responses to COVID in patients with antibody deficiencies
A new study aims to explore the immune response to COVID-19 infection and vaccination in patients with antibody deficiencies.
April 2021 North America Analysis
In the Spring edition of North America Analysis, we hear from Robert Lembo, from the National Institutes of Health, who turns the spotlight on training physician scientists and clinician investigators through the process of graduate medical education in the United States, and more.
Vicky Whittemore, PhD – National Institute of Neurological Disorders & Stroke, (NIH)
Dr Whittemore oversees a grant portfolio that includes basic, translational and clinical studies on epilepsy.
From insulin to immunotherapy: A century of discovery
Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.
Artificial Intelligence examines COVID misinformation on social media
A Northwestern Medicine study used Artificial Intelligence to analyse tweets and figure out how COVID misinformation on social media can erase scientific truths from public awareness.
Huntington’s disease: Present concern & therapeutic view
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the present concern and future therapeutic perspective on Huntington’s disease.
The promises and challenges of biomodifying technologies for the UK
Michael Morrison, Senior Researcher in Social Science at the Centre for Health, Law and Emerging Technologies (HeLEX), University of Oxford, sheds light on the promises as well as biomodifying technologies for the UK.
